Mary Broadfoot Walker: 83 years since a historical discovery
ABSTRACT Mary Broadfoot Walker was a Scottish physician who, in 1935, described in great detail the effect of an anticholinesterase drug (physostigmine) on the signs and symptoms of myasthenia gravis. An original five-minutes movie is available online and the skepticism of her contemporary British m...
Saved in:
| Main Authors: | Vitor Martinez de Carvalho, Eduardo de Almeida Guimarães Nogueira, Gleysson Rodrigues Rosa, Yara Dadalti Fragoso |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2017001100825&lng=en&tlng=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical characteristics and treatment outcomes of ocular myasthenia gravis at a tertiary eye care center in Eastern India
by: Thalluru Subhash, et al.
Published: (2025-06-01) -
Safety and effect of topical neostigmine ophthalmic solution in animal models
by: Chuthamas Ongprakobkul, et al.
Published: (2025-08-01) -
IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
by: E. D. Gasymly
Published: (2018-06-01) -
Effects of neostigmine on postoperative neurocognitive dysfunction: a systematic review and meta-analysis
by: Xuelei Zhou, et al.
Published: (2025-03-01) -
Incidence and Prevalence of Juvenile Myasthenia Gravis in the United States Between 2010 and 2020: Analysis of Two Claims Databases
by: Jiachen Zhou, et al.
Published: (2025-05-01)